Treatment of stat3 related diseases by iron chelators
WO2021064175A1
Compounds for preventing migration of cancer cells
WO2021038038A1
Multi-cell culture device and kit
WO2021023837A1
Inhibition of metastasis development by nangptl-4
WO2021013932A1
Polypeptides for treatment of aml
WO2021009281A1
A device and a method for monitoring a treatment of a body part of a patient with particles
WO2021001351A1
Plasmodium antibodies
WO2020254491A1
Sphingolipids for generating regulatory cd4+ t cells
WO2020234454A1
Combination treatment of cancer targeting energy metabolism and intracellular ph
WO2020193431A1
Novel inhibitors of histone deacetylase 10
WO2020187889A1
Expression constructs for the genetic modification of cells
WO2020165409A1
Prostate specific membrane antigen (psma) ligands comprising an amylase cleavable linker
WO2020079185A1
Dry pharmaceutical composition for inhalation
WO2020074708A1
Epstein-barr virus-like particles with broadened antigenic spectrum
EP3766968A1
Improving cas nuclease target specificity
AU2019276162A1
Combined prophylactic and therapeutic vaccines
EP3738972A1
Parvolysine
US2020316404A1
Detector and method for tracking an arrival time of single particles in an ion beam
US2020002723A1
Msbi sequences as an early marker for the future development of cancer and diseases of the cns and as a target for the treatment and prevention of these diseases
